Literature DB >> 31293022

Influence of family income and medical insurance coverage on health-related quality of life and optimism in cancer patients at a Hong Kong private hospital: A cross-sectional study.

Sai Yiu Richard Chiu1, Zuyao Yang2.   

Abstract

OBJECTIVE: Health-related quality of life (HRQL) and optimism are important health domains that express the physical, emotional, and psychological well-being of cancer patients. Previous studies have explored income and medical insurance coverage as predictors of their well-being with the aim to better understand their financial needs. The primary objective of this study was to examine the associations in the private health sector in Hong Kong.
METHODS: The study was conducted cross-sectionally with a structured questionnaire in traditional Chinese. HRQL was assessed with the RAND 12-item Health Survey, and optimism was assessed with the Life Orientation Test. The two primary predictors were family income and medical insurance coverage. The associations were tested using logistic regression, controlling for other sociodemographic and clinical covariates.
RESULTS: A total of 428 questionnaires were used in the regression model. After adjusting for other covariates, no significant association was observed with family income as the predictor. Medical insurance coverage was a significant and positive predictor of optimism with odds ratio of 2.30 and 95% confidence interval of 1.30 to 4.05 for the group with the most coverage with little to no coverage as the reference group.
CONCLUSIONS: The significant association between medical insurance coverage and optimism might be an indication that the medical cost was a financial burden to many cancer patients in Hong Kong. In addition to their medical needs, cancer support organization and health care practitioners must be able to recognize and assist with the financial needs of the cancer patients.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer; family income; financial stress; health inequity; medical insurance; oncology; optimism; quality of life

Mesh:

Year:  2019        PMID: 31293022     DOI: 10.1002/pon.5175

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  6 in total

1.  Assessment of the health utility of patients with leukemia in China.

Authors:  Xueyun Zeng; Mingjie Sui; Rui Liu; Xinyu Qian; Wenfeng Li; Erwei Zheng; Jinjin Yang; Jinmei Li; Weidong Huang; Hongbin Yang; Hongjuan Yu; Nan Luo
Journal:  Health Qual Life Outcomes       Date:  2021-02-27       Impact factor: 3.186

2.  Socioeconomic Determinants of Health-Related Quality of Life of Entrepreneurs. A Cross-Sectional Study.

Authors:  Daniel Puciato; Michał Rozpara; Marek Bugdol; Tadeusz Borys; Teresa Słaby
Journal:  Int J Environ Res Public Health       Date:  2021-11-18       Impact factor: 3.390

3.  Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study.

Authors:  Melissa S Y Thong; Daniela Doege; Linda Weißer; Lena Koch-Gallenkamp; Heike Bertram; Andrea Eberle; Bernd Holleczek; Alice Nennecke; Annika Waldmann; Sylke Ruth Zeissig; Ron Pritzkuleit; Michael Schlander; Hermann Brenner; Volker Arndt
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-13       Impact factor: 4.553

4.  Socioeconomic Determinants of Health and Their Unequal Distribution in Poland.

Authors:  Justyna Rój; Maciej Jankowiak
Journal:  Int J Environ Res Public Health       Date:  2021-10-15       Impact factor: 4.614

5.  Socio-economic correlates of quality of life in single and married urban individuals: a Polish case study.

Authors:  Daniel Puciato; Michał Rozpara; Marek Bugdol; Barbara Mróz-Gorgoń
Journal:  Health Qual Life Outcomes       Date:  2022-04-02       Impact factor: 3.186

6.  The role of community factors in predicting depressive symptoms among Chinese workforce: a longitudinal study in rural and urban settings.

Authors:  Wanlian Li; Guanghan Gao; Fei Sun; Lin Jiang
Journal:  BMC Public Health       Date:  2022-07-27       Impact factor: 4.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.